LncRNA EMX2OS interacts with mRNA more than other regulatory factors in TNBC patients, which may be a key regulatory factor related to the progression of TNBC 3; ORAI2 is up-regulated in TNBC cell lines, and ORAI2 knockdown will block the cell cycle of cancer cells and be more susceptible to cisplatin treatment.4 This evidence concerns the gene ORAI2 and cancer.